At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you
Has anyone else had experience of negotiating and agreeing a central price for a product or service (e.g. Drug Tariff) only to be then drawn in to attempts at a local PCT level to re-negotiate that price?
1 person agrees with this